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Indian Institute of Technology, Hauz Khas, New Delhi, India; and §Continuum-Dynamics Inc., Ewing, New JerseyABSTRACT Proper modeling of nonspecific salt-mediated electrostatic interactions is essential to understanding the binding
of charged ligands to nucleic acids. Because the linear Poisson-Boltzmann equation (PBE) and the more approximate gener-
alized Born approach are applied routinely to nucleic acids and their interactions with charged ligands, the reliability of these
methods is examined vis-a`-vis an efficient nonlinear PBE method. For moderate salt concentrations, the negative derivative,
SKpred, of the electrostatic binding free energy, DGel, with respect to the logarithm of the 1:1 salt concentration, [M
þ], for 33
cationic minor groove drugs binding to AT-rich DNA sequences is shown to be consistently negative and virtually constant
over the salt range considered (0.1–0.4 M NaCl). The magnitude of SKpred is approximately equal to the charge on the drug,
as predicted by counterion condensation theory (CCT) and observed in thermodynamic binding studies. The linear PBE is
shown to overestimate the magnitude of SKpred, whereas the nonlinear PBE closely matches the experimental results. The
PBE predictions of SKpred were not correlated with DGel in the presence of a dielectric discontinuity, as would be expected
from the CCT. Because this correlation does not hold, parameterizing the PBE predictions of DGel against the reported exper-
imental data is not possible. Moreover, the common practice of extracting the electrostatic and nonelectrostatic contributions to
the binding of charged ligands to biopolyelectrolytes based on the simple relation between experimental SK values and the elec-
trostatic binding free energy that is based on CCT is called into question by the results presented here. Although the rigid-dock-
ing nonlinear PB calculations provide reliable predictions of SKpred, at least for the charged ligand-nucleic acid complexes
studied here, accurate estimates of DGel will require further development in theoretical and experimental approaches.INTRODUCTIONMany important clinical drugs bind noncovalently to the
minor groove of B-type DNA duplexes containing three or
more consecutive AT basepairs (mG-binders) (1). These
small organic drugs are used to treat many conditions,
including cancer, genetic disorders, and viral and parasitic
diseases. Various structural and biophysical studies have
examined the noncovalent interactions that contribute to
the binding affinity between the mG-binders and B-DNA
(2–4). In particular, the complementarity of both shape
and electrostatic potential, as discussed in the Supporting
Material, between the drugs and the B-DNA as well as the
short-range van der Waals and H-bonding contacts enhance
binding affinity and contribute to the base sequence speci-
ficity (5–9). These studies, however, do not show the relative
importance of these noncovalent interactions in stabilizing
drug-DNA complexes (10–12). Understanding how these
different interactions contribute to binding at the atomic
level is critical to developing novel drugs with enhanced
binding affinity, specificity, and biological activity.
Several experimental studies have observed that the
binding affinities of mG-binders to B-DNA are very sensi-
tive to small variations in salt concentration. In the litera-
ture, this observation has been interpreted to mean that
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0006-3495/10/08/0879/8 $2.00formation of these complexes (10,13,14). If Kobs is the
experimental binding constant, and [Mþ] is the concentra-
tion of 1:1 salt in the bulk solution, then, in the absence of
competing multivalent cations, log(Kobs) is usually propor-
tional to log[Mþ] over a range of moderate salt concentra-
tions (15,16). The slope of a linear log(Kobs)-log[M
þ] plot
is called SKobs in the literature (17) and is negative for
cationic drug-DNA complex formation. A constant negative
SKobs over a moderate salt range has historically been inter-
preted as a characteristic of the polyelectrolyte effect and
originates from the high charge density of the negatively
charged phosphate groups on the polyanionic DNA back-
bone (18–20). Because SKobs is easy to obtain experimen-
tally, predicting it is an ideal test of electrostatic models.
The first theoretical attempt to explain the binding of
charged ligands to polyelectrolyte DNAwas the counterion
condensation theory (CCT) developed by Manning (18).
The CCT was originally based on a coarse-grained model
where the polyion (the DNA in our case) is treated as an
infinite line charge representing the projection of the nega-
tively charged phosphate groups onto the helical axis of
the DNA. The ionic solvent is modeled as a uniform
high dielectric medium, and the ions as point charges. The
CCT was later extended by Fenley et al. (21) to account
for the 3D arrangement of the phosphate groups obtained
from structural data. More recently, others have considered
more detailed nonuniform finite charge distributions within
the framework of the CCT (22–24), but the CCT lacksdoi: 10.1016/j.bpj.2010.04.066
880 Fenley et al.features, like full atomic detail and the dielectric discontinuity
between the interior and exterior of the molecule, that are
important in some predictions of electrostatic properties,
like sequence-dependent features of the electrostatic potential
and counterion distributions surrounding nucleic acids
(6,7,25). Therefore, theCCTmaynot reproduce experimental
data for systems in which these effects are important (26).
According to the Manning CCT (18),





 ¼ z; (1)
where z is the charge on the cationic drug. Following similar
assumptions, Record et al. (20) predict that SKobs ¼ zj
where j is the thermodynamic binding fraction, which
depends on the charge density of the nucleic acid. Both
theories assume that the polyelectrolyte effect is purely
entropic and arises when the ligand displaces counterions
that were bound to the DNA before association.
Other interpretations of SKobs have been discussed in the
literature. For instance, Anderson and Record (17) express
SKobs in terms of preferential interaction coefficients, which
take into account changes in the accumulation of cations and
the exclusion of anions around the DNA and ligand during
binding. If it is assumed that the only salt-dependent terms
in the binding free energy are in the electrostatic component
of the binding free energy, DGel, then, following Sharp et al.
(27), SKobs relates to the change in the osmotic pressure on
binding, DP, whereP is the osmotic pressure defined in the
Methods section, by:




 ¼ DP: (2)
The Poisson-Boltzmann equation (PBE) (6,28,29) can be
solved numerically to find a potential that can be integrated
by the methods of Sharp et al. (27) to calculate DGel. Unlike
the CCT, the PBE can make predictions of DGel that include
the 3D atomic structure of the biomolecules with low CPU
cost due to the algorithmic advances made in the past decade.
The PBE does not inherently include conformation change
effects. The molecules in this study undergo only very small
conformation changes on binding, as pointed out by Wilson
et al. (4). Therefore, not including these conformational
effects is a reasonable approximation, as we show in the
Discussion. PBE methods include both the nonlinear PBE
and its linear approximation, which is found by taking the
first order approximation to the exponential term in the
nonlinear PBE. The linear PBE is valid for small electrostatic
potentials. The pairwise generalized Born (GB) method
approximates the linear PBE by using an empirical Debye-
Hu¨ckel term (30,31) to account for nonspecific salt effects.
Some theoretical studies have used the nonlinear PBE to
investigate a limited number of drugs binding to nucleic
acids (27,28,32–38), whereas several other groups have
used either the linear PBE or GB model in lieu of the full
nonlinear PBE to study different electrostatic effects inBiophysical Journal 99(3) 879–886nucleic acids-charged ligand association processes (39–44).
Wang and Laughton used molecular dynamics and the
molecular mechanics/generalized Born approach to predict
the relative affinity of the Hoechst 33258 ligand for different
A/T-rich DNA sequences (41). In a newer follow-up study
from the same laboratory it was found that predictions of
the binding affinity of Hoechst 33258 to different DNA
sequences are better when the molecular mechanics/Pois-
son-Boltzmann surface accessible approach is used as
opposed to the molecular mechanics/generalized Born
surface accessible approach (45). However, none of these
studies have rigorously examined the validity of the linear
PBE approximation for a large set of nucleic acid-charged
ligand systems. Therefore, one of the main goals in this
study is to determine whether the linear PBE provides an
adequate approximation to the nonlinear PBE when investi-
gating salt-dependent drug-nucleic acid interactions. Talley
et al. (46) did address this question for protein-protein asso-
ciation, but their protein-protein complexes were generally
of lower net charge than the complexes examined here.
The complexes in this study are therefore expected to
exhibit more pronounced nonlinear behavior. To confirm
this expectation and to assess the ability of linear and
nonlinear PBE analyses to reproduce experimental results,
SKobs was calculated with the linear and nonlinear PBE
for the complexes in this study.
Unfortunately, extracting DGel directly from the experi-
mental data of the binding of charged ligands to nucleic
acids is not possible. The CCT predicts that DGel can be pre-
dicted by
DGel ¼ kT SKobs ln

Mþ
 þ C; (3)
where C is a term that does not depend on the salt concentra-
tion. This equation is model-independent, as it is simply
a thermodynamic identity. Manning then goes on to compute
C by making several assumptions, including that the electro-
static potential can be given by the Debye-Hu¨ckel equation
and that the atomic structure of neither the polyelectrolyte
nor the binding ligand is important to DGel. (18) These
assumptions lead to the prediction that C is independent of
the details of the binding partners and solely depend on the
charge density of the polyelectrolyte. Because the PBE
does consider this information, C is not necessarily indepen-
dent of all parameters except the charge density of the poly-
electrolyte, and as will be shown here, the PBE predictions of
DGel do indeed depend on these parameters.
Frequently, experimental groups (47–52) infer DGel from
the following equation:





which is a simplified version of Eq. 3. Once DGel is calcu-
lated, the nonelectrostatic binding free energy, DGnon-el
follows from:
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Whether the predictions of Eq. 4 agree with those of the
PBE is not clear, however. For instance, from Eq. 4 a larger
SKobs indicates a larger DGel, but this disagrees with the
results of our recent PBE study (53). If Eq. 4 is not valid,
then it is not possible to parameterize the PBE directly
against the experimental data that has been reported without
resolving the term C in Eq. 3. In this study, we report
a detailed investigation of the behavior of DGel with respect
to ln[Mþ] for a large number of DNA-drug complexes.FIGURE 1 Electrostatic binding free energy, DGel (kcal/mol), of the
propamidine-B-DNA complex (PDB id: 102D) as a function of the loga-
rithm of the concentration of a 1:1 salt, ln[NaCl] with different internal
dielectric constants. DGel is highly sensitive to the choice of interior dielec-
tric constant, 3in, changing from unfavorable to favorable. However, the
slope of the lines is fairly constant.THEORETICAL METHODS
The DNA-drug complexes in this study are listed in Table S1, and the
atomic coordinates of all the complexes are available in the RCSB Protein
Data Bank (http://www.rcsb.org). The complexes were prepared as
described in the Supporting Material.
The PBE calculations were carried out with an adaptive grid solver that is
described elsewhere (A. Boschitsch and M. Fenley, unpublished) at 1:1 salt
concentrations of 0.1-0.4 M at a temperature of 298 K. This PBE solver
produced results that were comparable to the more commonly used
APBS (54) PBE solver. The exterior dielectric constant, 3ext, was set at
80, and the interior dielectric constant, 3int, was fixed at 2. We discuss the
effect of 3int later. The dielectric boundary separating the solute and solvent
regions was the solvent excluded, SE, surface. No ion-exclusion region was
used because it has a consistent but small effect on our predictions of SKobs
(55). The dimensions of the grid were set to three times the largest dimen-
sion of the complex, and the fine grid spacing was 0.3 A˚. The reader is
referred to the Supporting Material for a more detailed description of the
PBE calculations.RESULTS AND DISCUSSION
Electrostatic binding free energy of drug-DNA
complexes
In this study, SKpred is considered rather than DGel because
DGel is sensitive to the PBE parameters. This is illustrated
in Fig. 1, where DGel is plotted against ln[NaCl] for several
values of 3int for propamidine interacting with AT-rich
B-DNA (PDB id: 102D). UnlikeDGel, which clearly exhibits
significant change, the slope of the DGel versus ln[NaCl]
curves, which is proportional to SKpred, is effectively the
same for all 3int. Comparable variations in DGel are observed
when varying the dielectric interface definitions used in the
PBE calculations (data not shown), although, SKpred is essen-
tially invariant under such changes. Similar conclusions on
different nucleic acid-charged ligand systems have been
made in other PBE studies (56,57).
Intuitively, one would expect the desolvation cost to be
unfavorable and the Coulombic interactions to be favorable
for the association of unlike charges with the net DGel
remaining small. This expected anticorrelation between the
Coulombic term and the reaction field term was observed
for the complexes in this study (results not shown), where
the Coulombic term is almost equal in magnitude but of
opposite sign to the reaction field contribution. This compen-sation effect between the Coulombic and reaction field
energies was first noted by Shaikh et al. (42) and Jayaram
et al. (58) in a free energy component analysis of 25 minor
groove drug-DNA complexes using a modified GB model
(42,58). More recently, a molecular dynamics study of the
essential subunit PA-PB1 interaction in the influenza virus
RNA polymerase using the molecular mechanics/Poisson-
Boltzmann surface accessible and molecular mechanics
generalized Born surface accessible protocols also showed
this compensation phenomena between the Coulombic and
reaction field binding free energies (59). When the drug
and the DNA are far apart, there is a net favorable electro-
static binding contribution, originating from the Coulombic
term that is only weakly affected by the choice of PBE
parameters. As they come in contact however, the unfavor-
able reaction field term grows and eventually dominates the
Coulombic energy contribution. The sensitivity of DGel to
the parameters is largely attributable to the reaction field
contribution. This desolvation energy is also what distin-
guishes the predictions of the CCT from those of the PBE
in a simplistic sense. Because the CCT does not include
a dielectric discontinuity, there is no desolvation cost, and
therefore the C in Eq. 3 is not dependent on the details of
the molecular surface.
Some attempts have been made to identify what surface
definition should be used to construct the solute-solvent
dielectric boundary in PBE calculations, but the results
obtained by different groups are conflicting. In one study,
it was found that the van der Waals surface reproduces the
effects of charge mutations on the binding affinity of two
different RNA-protein complexes better than the SE surface
(56). On the other hand, a more recent PBE study of the
association of mRNA cap analogs to the translation initia-
tion factor eIF4E showed that both the van der Waals andBiophysical Journal 99(3) 879–886
FIGURE 3 Electrostatic binding free energies, DGel (kcal/mol), of all 33
drug-DNA complexes calculated using the nonlinear PBE with an internal
dielectric constant of 78 versus SKpred. Unlike the previous figure, these two
quantities are correlated, with an R2¼ 0.96. However, it is not clear whether
the near lack of a dielectric discontinuity is reasonable.
882 Fenley et al.SE models provide similar predictions of the effects of
mutations on the binding energetics (57). Based on these
and our own PBE studies (53,60), we believe it is clear
that one should be cautious when drawing any conclusions
about whether electrostatics stabilizes or destabilizes
binding because, by simply altering the dielectric boundary
definition and the value of the interior dielectric constant,
one can change DGel from positive to negative.
To solve the parameterization problems noted above,
one would like to use the reported experimental thermody-
namic binding data, but, as mentioned before, the ability
of Eq. 4 to predict DGel is questionable. As can be seen
in Fig. 2, DGel and SKpred were not correlated for the choice
of PBE parameters listed in the Theoretical Methods
section. As has been found in other PBE studies (36,38,61),
DGel is positive. The problem with Eq. 4 seems to be that it
does not account properly for the dielectric discontinuity
between the solute and solvent regions. In Fig. 3, DGel
was plotted against SKpred where each quantity was calcu-
lated with an 3int of 78, so that the dielectric discontinuity
was nearly eliminated. This is the limit considered by the
CCT, and we would therefore expect Eq. 4 to agree with
the predictions of the PBE in this limit. We did not eliminate
the dielectric discontinuity completely because this is not
possible with our PBE solver, but this should illuminate
the behavior in this limit. In this case, DGel was strongly
correlated with SKpred with an R
2 ¼ 0.96. This indicates
that the primary difference between the predictions of
DGel by the CCTand those by the PBE arise from the dielec-
tric discontinuity, whereas incorporating a realistic charge
distribution is relatively unimportant. However, several
studies have indicated that including a dielectric disconti-
nuity is vital for reproducing other physical parameters
(8,62,63), and we therefore do not feel that this choice of
3in should be used.FIGURE 2 Electrostatic binding free energies, DGel (kcal/mol), of all 33
drug-DNA complexes calculated using the nonlinear PBE with a dielectric
constant of 2 versus SKpred. These two quantities are not correlated. There-
fore, the experimental values of SKobs should not be used to predict the
value of DGel using Eq. 4 in the main text.
Biophysical Journal 99(3) 879–886Effects of the details of the charge distribution
on SKpred
SKpred is fairly independent of changes in the 3D charge
distribution that preserve the total charge on the complex,
as can be seen from Fig. 4, where SKpred calculated with
a formal charge distribution is similar to that obtained using
an all-atom charge assignment. These observations concur
with an earlier study by Sharp et al. (27) that modeled the
binding of DAPI to DNA as a cylinder-sphere interaction
and compared the results to a classical all-atom DNA-drug
model. They found that SKpred predicted by all-atom models
differs by <3% from that obtained with the coarse-grained
models. Such errors are less than those in experimental esti-
mates of SKobs. Therefore consideration of full atomic detail
does not appear to be necessary when computing SKpred of
charged ligand-nucleic acid complexes. Because the charge
distribution does not seem to significantly affect SKpred for
the complexes in this study, it seems that the ionizable
groups are the major contributors to SKpred, with the dipolar
groups playing a minor role. A thermodynamic study on the
contribution of the closing basepair to the stability of RNA
tetraloops supports this observation (64).Comparing the predictions of the nonlinear PBE
to experimental binding data
In Table 1, the available thermodynamic salt-dependent
binding data for these complexes are compared to our
nonlinear PBE predictions, and they are in excellent agree-
ment. This strong correlation between the experimental
thermodynamic data obtained from different laboratories
and these nonlinear PBE predictions supports the use of
the nonlinear PBE in accurately predicting SKobs for these
drug-DNA systems. Because the predictions of the linear
PBE deviate strongly from the experimental data, the
FIGURE 4 SKpred of all 33 drug-DNA complexes considered here (iden-
tified by their PDB ids) and calculated using both the linear PBE and the
nonlinear PBE are shown. The nonlinear PBE results obtained with
the formal charge assignment for both drug and B-DNA are also shown.
The complexes are grouped by net charge, with complexes 109D–302D
having a charge of 1e, complexes 102D–360D having a charge of 2e, and
complex 1M6F having a charge of 3e.
TABLE 1 Theoretical predictions of the salt dependence of
the binding affinity, SKpred, using the NLPBE compared to the
available experimental thermodynamic binding affinity data
(SKobs) for various minor groove drug-DNA complexes
reported in the literature (12,49,74–80)
PDB name Experimental SKobs SKpred (NLPBE)
1D30 2.3 2.0
1D86 1.51; 1.63 2.0
1EEL ~2 1.9
227D ~2 2.1
264D 0.90; 0.995 0.02 1.0
2DND 0.79; 0.97 0.9
2B0K 1.505 0.06 1.8
2DBE 1.45; 2.02 2.0
2FJV 1.8 1.9
2I2I 1.955 0.02; 1.815 0.01 2.1
2I5A ~2 2.0
NLPBE, nonlinear PBE; PBE, Poisson-Boltzmann equation.
PB Analysis of Drug-DNA Binding 883nonlinear PBE should be used for highly charged complexes
like these.
Because predictions from static single-conformation PBE
calculations accurately reproduce the experimental data, it
appears that conformational flexibility can be neglected
for SK predictions in these systems. The role of conforma-
tional dependence is more pronounced and its inclusion
becomes necessary for more complicated nucleic acid
systems where induced fit effects or intercalation are an
integral part of the binding mechanism (65).
The reader is referred to the Supporting Material for
a comparison of our PBE predictions of SKobs to similar
PBE results reported in the literature.Linear versus nonlinear PBE predictions of SKpred
SKpred obtained with the nonlinear PBE is compared to that
obtained with the linear PBE in Fig. 4. For all 33 DNA-drug
complexes, the magnitude of SKpred obtained from the linear
PBE is larger than that obtained from the nonlinear PBE by
at least 51%. This overestimation has also been observed in
predictions of SKpred for charged protein-protein complexes(46) and glutamine synthetase and glutaminyl synthetase
bound to their cognate tRNA (66). For the protein-protein
complexes considered by Talley et al. (46), the overestima-
tion of the magnitude of SKobs using the linear PBE
compared with the nonlinear results is much smaller than
for the drug-DNA complexes considered here. This is
expected, given the larger charge densities of the drug-
DNA complexes, and is consistent with the large differences
between the linear and nonlinear PBE SK predictions
obtained for the more highly charged tRNA synthetase-
tRNA complexes examined by Bredenberg et al. (66). The
reason why the linear PBE overestimates the magnitude of
SKobs is explained using a simple model in the Supporting
Material.
To determine whether the difference between the linear
and nonlinear PBE, SKpred is predictable, the difference,
DSK ¼ SKpred(nonlinear PBE)  SKpred(linear PBE), was
calculated as a function of ligand charge. The result, shown
in Fig. 5, suggests that DSK is proportional to the charge on
the ligand. If this pattern holds for other complexes, then the
predictions of the linear PBE could be corrected to agree
more closely with those of the nonlinear PBE.Comparing the nonlinear PBE predictions
of SKpred to those of the CCT
In Fig. 6, the values of SKpred are plotted against the net
charge of the cationic drug, and the magnitude of SKpred is
generally very close to the net charge on the drug, irrespec-
tive of the specific charge distribution and geometry of
either the drug or the DNA. This result is in good agreement
with the CCTand with the PBE analysis carried out by Rou-
zina and Bloomfield (67) that uses a coarse-grained DNA
model. It is indeed striking to see the extent of agreement
between the current and previous 3D PBE analyses and
CCT predictions given that the 3D PBE and the CCT are
based on very different physical models.Biophysical Journal 99(3) 879–886
FIGURE 5 The difference, DSKpred, between SKpred calculated with the
nonlinear PBE and SKpred calculated with the linear PBE plotted against
the charge on the ligand. These quantities seem to be proportional. There-
fore, it might be possible to find a way to correct the linear solution to
approximate that of the nonlinear PBE.
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The binding of mG-binders was studied using the nonlinear
PBE, and these results were used to assess the suitability
of using the simpler linear PBE for modeling such systems.
We believe the results show clearly that the linear PBE
substantially overestimates the magnitude of SKpred with
large deviations from the experimental SKobs. On the other
hand, the nonlinear PBE provides SKpred results that agree
closely with experimental data as well as the predictions
of the CCT. Hence, the linear PBE does not provide an
adequate description of the electrostatic properties of these
complexes.FIGURE 6 SKpred calculated by the nonlinear PBE is plotted against the
charge on the cationic drug, z, for all 33 drug-DNA complexes. SKpred and
the net drug charge are clearly correlated, as predicted by the CCT. The
slope of the best fit line is 0.99 5 0.02. This data is in good agreement
with the CCT.
Biophysical Journal 99(3) 879–886The nonlinear PBE predictions of SKpred closely matched
those of the CCT, whereas the PBE predictions of DGel did
not agree with those of the CCT. As indicated by our PBE
results in the limit of no dielectric discontinuity, this is prob-
ably due to the lack of consideration of a low dielectric
region in the CCT. The inclusion of a realistic charge distri-
bution had a much smaller effect than the inclusion of
a dielectric discontinuity.
This PBE analysis questions the popular method of
extracting DGel from experimental thermodynamic binding
data of charged ligand-nucleic acid complexes, polysaccha-
rides-proteins, and other charged biomolecular complexes
(51,68,69). Because the PBE predictions do not agree with
Eq. 4, extracting DGel directly from thermodynamic binding
data is not possible, even though Eq. 4 is used widely
(51,69–71) to do this. The common practice of inferring
that electrostatic interactions are more important when the
magnitude of SKobs is large (72), as implied by Eq. 4, is
also questioned by these results, and these concerns should
be reexamined by further experimental and theoretical
investigations. Also, this work questions the value of obtain-
ing SKobs. Traditionally, it has been valued because of its
presumed use to compute DGel. If this is not possible, as
indicated by these results, then the usefulness of deter-
mining SKobs is debatable. The question as to whether
electrostatic interactions favor or disfavor the binding of
charged ligands to nucleic acids remains unanswered in
light of the sensitivity of PBE predictions of DGel to various
input parameters. Proper parameterization of the PBE
together with improved solvent descriptions must be devel-
oped and validated against reliable experimental data or all-
atom molecular dynamics before these important questions
can be answered.
In summary, the nonlinear PBE implementations to treat
electrostatic interactions in DNA and DNA-ligand systems
have evolved to a stage where reliable predictions of SKpred
can be made. However, further advances in a molecular
level understanding of binding and, in particular, the effects
of solvation (73) seem to be necessary before DGel can be
reliably computed for biomolecular complexes.SUPPORTING MATERIAL
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